Literature DB >> 8877727

Interferon-beta prevents the upregulation of interleukin-8 expression in human melanoma cells.

R K Singh1, M Gutman, N Llansa, I J Fidler.   

Abstract

The constitutive expression of interleukin-8 (IL-8) by human melanoma cells correlates with their metastatic potential. The exposure of human melanoma cells to the inflammatory cytokines IL-1 beta or tumor necrosis factor-alpha (TNF-alpha) upregulated IL-8 expression in a time-dependent and concentration-dependent manner. This enhanced expression of IL-8 was inhibited by cycloheximide or actinomycin-D. Treatment of melanoma cells with interferon (IFN) alpha, beta, or gamma did not affect the constitutive expression of IL-8, but IFN-alpha and IFN-beta blocked the upregulation of IL-8 expression in cells treated with IL-1 beta or TNF-alpha subsequent to or simultaneously with the IFN. These data suggest that the expression of IL-8 in human melanoma cells can be upregulated by inflammatory cytokines and that IFN-alpha and IFN-beta can counterregulate this stimulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877727     DOI: 10.1089/jir.1996.16.577

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

Review 1.  Interferons as antiangiogenic agents.

Authors:  Daniel J Lindner
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

2.  Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.

Authors:  M Luca; S Huang; J E Gershenwald; R K Singh; R Reich; M Bar-Eli
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.

Authors:  J E De Larco; B R Wuertz; K A Rosner; S A Erickson; D E Gamache; J C Manivel; L T Furcht
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 4.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

5.  Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.

Authors:  Anastasia Bachmann; Brigitte Hanke; Rainer Zawatzky; Ubaldo Soto; Jan van Riggelen; Harald zur Hausen; Frank Rösl
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha.

Authors:  S Ozawa; H Shinohara; H O Kanayama ; C J Bruns; C D Bucana; L M Ellis; D W Davis; I J Fidler
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

7.  Evidence for the causal role of endogenous interferon-alpha/beta in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms.

Authors:  Marya F McCarty; Diane Bielenberg; Cherrie Donawho; Corazon D Bucana; Isaiah J Fidler
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

8.  The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma.

Authors:  Carmela Passaro; Francesco Borriello; Viviana Vastolo; Sarah Di Somma; Eloise Scamardella; Vincenzo Gigantino; Renato Franco; Gianni Marone; Giuseppe Portella
Journal:  Oncotarget       Date:  2016-01-12

Review 9.  Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.

Authors:  Ruan F V Medrano; Aline Hunger; Samir Andrade Mendonça; José Alexandre M Barbuto; Bryan E Strauss
Journal:  Oncotarget       Date:  2017-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.